Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $48,925 | 22 | 66.7% |
| Food and Beverage | $13,219 | 689 | 18.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $5,171 | 3 | 7.0% |
| Consulting Fee | $3,373 | 2 | 4.6% |
| Travel and Lodging | $2,484 | 5 | 3.4% |
| Education | $194.05 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $38,544 | 124 | $0 (2022) |
| Dexcom, Inc. | $19,673 | 40 | $0 (2022) |
| Medtronic, Inc. | $3,168 | 12 | $0 (2022) |
| Amgen Inc. | $2,150 | 48 | $0 (2024) |
| Lilly USA, LLC | $1,701 | 120 | $0 (2022) |
| Medtronic MiniMed, Inc. | $1,297 | 19 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $826.86 | 45 | $0 (2022) |
| Abbott Laboratories | $752.53 | 43 | $0 (2023) |
| Corcept Therapeutics | $624.38 | 36 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $597.99 | 34 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,282 | 2 | Amgen Inc. ($1,267) |
| 2023 | $24.22 | 1 | Abbott Laboratories ($24.22) |
| 2022 | $45,743 | 258 | Novo Nordisk Inc ($37,135) |
| 2021 | $14,512 | 213 | DEXCOM, INC. ($7,895) |
| 2020 | $9,887 | 162 | Dexcom, Inc. ($6,369) |
| 2019 | $1,779 | 89 | Novo Nordisk Inc ($355.44) |
| 2018 | $139.06 | 2 | Companion Medical, Inc. ($124.99) |
All Payment Transactions
727 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/12/2024 | Amgen Inc. | Prolia (Biological) | Consulting Fee | Cash or cash equivalent | $1,266.50 | General |
| Category: Bone Health | ||||||
| 01/04/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Diabetes Care | ||||||
| 12/21/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Bone Health | ||||||
| 12/16/2022 | Lilly USA, LLC | BAQSIMI (Drug), LYUMJEV | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Diabetes | ||||||
| 12/15/2022 | PFIZER INC. | SOMAVERT (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/14/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Diabetes | ||||||
| 12/13/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Diabetes | ||||||
| 12/12/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: Diabetes | ||||||
| 12/08/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: Cardio-renal | ||||||
| 12/08/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Endocrinology | ||||||
| 12/07/2022 | Medtronic, Inc. | MINIMED 770G (Device) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: Durable Pump | ||||||
| 12/06/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Bone Health | ||||||
| 12/06/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Diabetes Care | ||||||
| 12/06/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $1.06 | General |
| Category: Diabetes Care | ||||||
| 12/01/2022 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/01/2022 | EUSA Pharma (US) LLC | Sylvant (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Hematology | ||||||
| 12/01/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Diabetes | ||||||
| 11/28/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: Diabetes | ||||||
| 11/22/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 11/22/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $2.27 | General |
| 11/21/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Diabetes Care | ||||||
| 11/21/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Diabetes Care | ||||||
| 11/21/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 275 | 338 | $98,990 | $25,030 |
| 2022 | 12 | 832 | 26,219 | $693,885 | $331,393 |
| 2021 | 13 | 878 | 18,899 | $554,647 | $258,857 |
| 2020 | 15 | 805 | 5,207 | $340,965 | $136,184 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 96 | 113 | $32,770 | $8,271 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 99 | $28,170 | $6,131 | 21.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 30 | 30 | $12,150 | $3,283 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 27 | $10,535 | $2,732 | 25.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 50 | $9,000 | $2,724 | 30.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $6,365 | $1,890 | 29.7% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 15 | 20,160 | $288,691 | $151,321 | 52.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 51 | 4,440 | $146,520 | $76,160 | 52.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 372 | 651 | $130,515 | $58,751 | 45.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 65 | 291 | $34,338 | $15,910 | 46.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 53 | 60 | $16,947 | $7,599 | 44.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 62 | 76 | $15,058 | $6,321 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 67 | $9,453 | $4,423 | 46.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 39 | 41 | $9,143 | $4,177 | 45.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 62 | 265 | $10,600 | $2,764 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $4,770 | $2,002 | 42.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 25 | 25 | $2,850 | $1,252 | 43.9% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2022 | 25 | 125 | $25,000 | $711.96 | 2.8% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2021 | 13 | 13,650 | $195,468 | $99,526 | 50.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 45 | 3,720 | $122,760 | $60,538 | 49.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 347 | 588 | $103,080 | $53,983 | 52.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 70 | 248 | $29,261 | $13,913 | 47.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 84 | 84 | $22,124 | $9,600 | 43.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 85 | 95 | $16,535 | $6,885 | 41.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 40 | 42 | $9,358 | $4,455 | 47.6% |
About Dr. Jason Sloane, MD
Dr. Jason Sloane, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2013. The National Provider Identifier (NPI) number assigned to this provider is 1336584390.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Sloane, MD has received a total of $73,366 in payments from pharmaceutical and medical device companies, with $1,282 received in 2024. These payments were reported across 727 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($48,925).
As a Medicare-enrolled provider, Sloane has provided services to 2,790 Medicare beneficiaries, totaling 50,663 services with total Medicare billing of $751,465. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Syracuse, NY
- Active Since 05/05/2013
- Last Updated 06/23/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1336584390
Products in Payments
- Rybelsus (Drug) $23,868
- Ozempic (Drug) $11,843
- DEXCOM G6 TRANSMITTER (Device) $7,895
- DEXCOM G6 CGM SYSTEM (Device) $6,369
- Dexcom G6 Transmitter (Medical Supply) $5,410
- InPen (Device) $3,140
- Minimed 670G System (Device) $1,372
- Prolia (Biological) $1,364
- TRULICITY (Drug) $767.41
- EVENITY (Biological) $658.34
- Korlym (Drug) $624.38
- FARXIGA (Drug) $562.69
- Kerendia (Drug) $430.77
- BAQSIMI (Drug) $397.37
- SOLIQUA 100/33 (Biological) $365.08
- TOUJEO (Biological) $311.64
- AFREZZA (Drug) $296.83
- FREESTYLE LIBRE 2 (Device) $284.47
- FreeStyle Libre 2 (Device) $218.79
- JANUVIA (Drug) $213.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Syracuse
Geeta Sangani, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $40,317
Ruth Weinstock, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $16,799
Dr. Padma Lal, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $4,754
Beth Anne Piper, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $3,840
Emily Skutnik, Do, DO
Endocrinology, Diabetes & Metabolism — Payments: $1,699
Lewis Johnson, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $674.76